Jean-Michel Boers
Vorstandsvorsitzender bei Boehringer Ingelheim Pharmaceuticals, Inc.
Profil
Jean-Michel Boers is currently the President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. He previously served as the Chairman & Chief Executive Officer at Boehringer Ingelheim France SASU.
He holds an MBA from The University of Texas at Austin and a graduate degree from Radboud University Nijmegen.
Aktive Positionen von Jean-Michel Boers
| Unternehmen | Position | Beginn |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Vorstandsvorsitzender | 31.07.2020 |
Ehemalige bekannte Positionen von Jean-Michel Boers
| Unternehmen | Position | Ende |
|---|---|---|
Boehringer Ingelheim France SASU
 Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Vorstandsvorsitzender | - |
Ausbildung von Jean-Michel Boers
| Radboud University Nijmegen | Graduate Degree |
| The University of Texas at Austin | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Boehringer Ingelheim France SASU
Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
